Colonic enteric nervous system in patients with familial amyloidotic neuropathy.
The colonic enteric nervous system was investigated in autopsy specimens from 12 patients with familial amyloidotic neuropathy (FAP) and 9 controls. The infiltration of amyloid deposits in the enteric nervous system was studied by double staining for amyloid and nerve elements. The myenteric plexus was immunostained for protein gene product (PGP) 9.5, vasoactive intestinal peptide (VIP), substance P and nitric oxide synthase (NOS). The immunostained nerve elements were quantified by computerised image analysis. Double staining revealed that there was no amyloid infiltration in the ganglia, or in the nerve fibres in the colonic enteric nervous system of FAP patients. The relative volume density of PGP 9.5-immunoreactive nerve fibres in both the circular and the longitudinal muscle layers in FAP patients did not differ significantly from that of controls. The relative volume density of VIP-immunoreactive nerve fibres in the circular muscle layer was significantly decreased in FAP patients compared with controls, but not in the longitudinal layer. The number of VIP-immunoreactive neurons/mm2 myenteric ganglia was significantly decreased in FAP patients. There were no statistical differences in the relative volume density for substance P- and NOS-immunoreactive nerve fibres between FAP patients and controls, nor was there any difference between FAP patients and controls regarding the number of NOS- and substance P-immunoreactive neurons/mm2 myenteric ganglia. It is concluded that the colonic enteric nervous system as a whole is intact and is not damaged by amyloid infiltration. The present observation of a reduction of VIP-immunoreactive nerve fibres and neurons in myenteric plexus of FAP patients might be one of the factors that contribute to the motility disorders seen in FAP patients.
Department of Medicine, Umeå University Hospital and University, Sweden.
I
I
Anan
M
M
El-Salhy
Y
Y
Ando
S
S
Forsgren
N
N
Nyhlin
H
H
Terazaki
N
N
Sakashita
O B
OB
Suhr
D000328:Adult; D000682:Amyloid / Q000378:metabolism; D017772:Amyloid Neuropathies / Q000378:metabolism* / Q000473:pathology*; D003106:Colon / Q000294:innervation* / Q000473:pathology; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009197:Myenteric Plexus / Q000378:metabolism* / Q000473:pathology*; D009412:Nerve Fibers / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D011228:Prealbumin / Q000378:metabolism; D013373:Substance P / Q000378:metabolism; D013869:Thiolester Hydrolases / Q000378:metabolism; D043222:Ubiquitin Thiolesterase; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism
D000682:Amyloid; D011228:Prealbumin; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D019001:Nitric Oxide Synthase; D013869:Thiolester Hydrolases; D043222:Ubiquitin Thiolesterase